New ALS Better Care Act Sets $800 Medicare Supplement to Boost Specialized Clinic Access by 2027

Managing ALS is an exhausting marathon that requires a small army of specialists—neurologists, physical therapists, speech pathologists, and respiratory experts. Currently, many specialized clinics struggle because Medicare doesn't always reimburse them enough to cover the high costs of this team-based care. Section 3 of the ALS Better Care Act changes the math by introducing a single, supplemental payment of $800 per visit for ALS-related services, starting January 1, 2027. This isn't just a one-time fix; the bill mandates that this amount increases annually based on a 'market basket' cost index, ensuring that as the cost of medical supplies and labor goes up, the support for these clinics doesn't fall behind.

A Comprehensive Care Package

Under the proposed law, 'ALS-related services' covers everything from occupational therapy and dietary support to the complex coordination of durable medical equipment like ventilators or specialized wheelchairs (Section 1861 amendment). For a patient, this means instead of navigating a fragmented system of different offices, they can access a 'one-stop-shop' clinic where the entire team is supported by a dedicated Medicare payment. Importantly, the bill requires these payments to be made on an 'assignment-related' basis. In plain English: the provider accepts the Medicare payment as the full amount, and the patient pays zero out-of-pocket for these specific supplemental services—no deductibles, no coinsurance.

Future-Proofing and Research

Policy often moves slower than science, but this bill includes a 'look-ahead' mechanism. By 2030, and every three years after, the Comptroller General must report on whether that $800 payment is still fair based on what private insurers are paying. The bill also explicitly allows for payment bumps if a clinic is using expensive new medical technologies or participating in clinical trials listed on clinicaltrials.gov. This is a big deal for innovation; it effectively subsidizes the providers who are doing the heavy lifting of testing tomorrow’s cures while treating today’s patients.

Cutting the Red Tape in Trials

Beyond the clinic walls, the bill targets the bureaucratic hurdles that slow down medical breakthroughs. Within 90 days of the bill becoming law, the Secretary of Health and Human Services must deliver a 'no-nonsense' report identifying exactly why ALS clinical trials are struggling with staffing and administration (Section 4). For families waiting on a miracle, this is intended to spotlight the bottlenecks in the research pipeline, moving from 'we should do something' to a concrete list of legislative fixes to get treatments through the lab and into the pharmacy faster.